Literature DB >> 15013773

Alpha-chimaerin exists in a functional complex with the Cdk5 kinase in brain.

Robert Z Qi1, Yick-Pang Ching, Hsiang-Fu Kung, Jerry H Wang.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) in association with its neuronal activators p35 and p39 shows a complex involvement in the control of neurocytoskeletal dynamics. Here we show that alpha-chimaerin, a GTPase-activating protein specific for Rac and Cdc42, is a p35-binding protein. The interaction domains of p35 and alpha-chimaerin were delineated. In transfected HeLa cells, p35 and alpha-chimaerin displayed an overlapping distribution pattern and they could be co-immunoprecipitated from the cell lysate. As alpha-chimaerin has a regulatory function in actin repolymerization, these results suggested that the regulation of neurocytoskeleton dynamics by Cdk5 is mediated at least in part via alpha-chimaerin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013773     DOI: 10.1016/S0014-5793(04)00174-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Alpha2-chimaerin interacts with EphA4 and regulates EphA4-dependent growth cone collapse.

Authors:  Lei Shi; Wing-Yu Fu; Kwok-Wang Hung; Cassandra Porchetta; Christine Hall; Amy K Y Fu; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

2.  S-Ketamine Exerts Antidepressant Effects by Regulating Rac1 GTPase Mediated Synaptic Plasticity in the Hippocampus of Stressed Rats.

Authors:  Xianlin Zhu; Fan Zhang; Fuxia Yan; Zaiping Wang; Yufeng You; Hongbai Wang; Su Yuan; Banglin Wu; Rongyu Zhu; Dawei Liu
Journal:  Cell Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.046

3.  Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.

Authors:  Matthew Brown; Tom Jacobs; Britta Eickholt; Giovanna Ferrari; Mabel Teo; Clinton Monfries; Robert Z Qi; Thomas Leung; Louis Lim; Christine Hall
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.